
Opinion|Videos|January 23, 2025
Seamless Transitions: Supporting Patients Through Treatment, Monitoring, and Maintenance
Panelists discuss how industry-provided patient support services can assist patients receiving bispecific antibodies, particularly in monitoring and follow-up care, and how these services can support patients transitioning from active treatment to maintenance or posttreatment care.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What role would these services play in assisting patients receiving bispecific antibodies, particularly regarding monitoring and follow-up care to ensure optimal outcomes?
- How can industry-provided patient support services help patients transition from active treatment to maintenance or posttreatment care?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Zanubrutinib Safe, Effective in Real-World CLL/SLL Cohort
2
Promises and Pitfalls of AI in Health Care
3
Paul Ryan Champions Health Care Policy Reform, AI Amid Government Shutdown
4
Review Outlines Shared Pathways Between CKD, VHD
5














































